Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2024 09:54 ET | Source: Research and Markets

Juvenile Rheumatoid Arthritis Treatments Pipeline Landscape Report 2024: Strategic Collaborations and Development Activities, Advanced Therapeutics Poised to Transform Outcomes

Dublin, Aug. 06, 2024 (GLOBE NEWSWIRE) -- The "Juvenile Rheumatoid Arthritis - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The global medical community turns...
June 25, 2024 12:36 ET | Source: Research and Markets

Rheumatoid Arthritis Market and Epidemiology Forecast 2024-2034 Featuring Analysis of ATI-450 (Aclaris Therapeutics) and Olumiant/Baricitinib (Eli Lilly/Incyte)

Dublin, June 25, 2024 (GLOBE NEWSWIRE) -- The "Rheumatoid Arthritis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
May 31, 2021 07:38 ET | Source: Research and Markets

US Rheumatoid Arthritis Market and Competitive Landscape Report 2021-2026: Pipeline Products, Epidemiology, Market Valuations and Forecasts, Drugs Sales

Dublin, May 31, 2021 (GLOBE NEWSWIRE) -- The "US Rheumatoid Arthritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering. US Rheumatoid Arthritis...
May 28, 2021 08:33 ET | Source: Research and Markets

Global Rheumatoid Arthritis Clinical Trial Pipeline Report 2021: Clinical Trial Stages, Drug Mechanism Classes, Companies, Short-term Launch Highlights

Dublin, May 28, 2021 (GLOBE NEWSWIRE) -- The "Global Rheumatoid Arthritis Clinical Trial Pipeline Highlights - 2021" report has been added to ResearchAndMarkets.com's offering. Rheumatoid Arthritis...
March 18, 2021 21:30 ET | Source: DelveInsight Business Research LLP

Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight

Los Angeles, USA , March 18, 2021 (GLOBE NEWSWIRE) -- Novel Rheumatoid Arthritis drugs succeed in the clinical trials: A status report by DelveInsight The Rheumatoid Arthritis Pipeline is robust as...